The market for host cell protein testing is highly fragmented, featuring a mix of global life science giants and specialized boutique firms. In 2026, the competition is fiercer than ever, with companies vying to offer the most sensitive and user-friendly assay kits. This "arms race" in analytical technology is a win for the biopharmaceutical industry, as it drives down costs and improves the...
0 Commentarios
0 Acciones
233 Views
0 Vista previa
Spanish 
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek